JPRN-UMIN000002385已完成2 期
A phase II, multicenter, study for newly diagnosed glioblastomas using boron neutron capture therapy, additional X-ray treatment and chemotherapy - BNCT, XRT plus chemotherapy for newly diagnosed GBM
Dept. of Neurosurgery, Osaka Medical College0 个研究点目标入组 45 人开始时间: 2009年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who have been treated with chemotherapy or radiotherapy. 2) Female patients in definitive or possible pregnancy or in breast-feeding. 3) Patients with phenylketonuria. 4) Patients with grade III or IV in NYHA classification. 5) Patients with cerebrospinal fluid dissemination. 6) Other patients whose participation in the present study is considered inappropriate by a Principal Investigator or Clinical Investigator.
研究者
相似试验
进行中（未招募）
不适用
A phase II, multicentre, clinical study evaluating the safety and efficacy of Treosulfan-based conditioning of allogenic transplantation of haemopoietic stem-cells in patients affected by Thalassemia Major - NDEUCTR2005-005913-40-ITOSPEDALE POLICLINICO S. MATTEO10
进行中（未招募）
不适用
A multicentre phase I-II study to investigate the combination of bendamustine with weekly paclitaxel as first or second line therapy in patients with metastatic breast cancer - RitaEUCTR2004-004880-31-DEGerman Breast Group Forschungs GmbH60
未知
2 期
A phase 2 multicenter clinical study evaluating the safety and efficacy of Nilotinib in patients with Imatinib- resistant/intolerant CML in chronic phaseChronic myelogenous leukemiaJPRN-UMIN000001927Tokyo STI Study Group50
尚未招募
2 期
Gene Xpert XDR-TB Kit EvaluatioCTRI/2019/07/020139Foundation for Innovative New Diagnostics India
进行中（未招募）
2 期
A Phase II, Multi-Center, Investigator-Initiated Study of Dasatinib against AITL and Other T Follicular Helper Cell LymphomaRelapsed/refractory T Follicular Helper Cell LymphomaJPRN-jRCT2031190079Chiba Shigeru18